← Eichor
Condition: Recurrent Pericarditis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Recurrent Pericarditis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)
Phase 3 · 27 location(s) · Cardiol Therapeutics Inc. · NCT06708299Transition to KPL-387 Monotherapy Dosing & Administration Study
Phase 2 · 39 location(s) · Kiniksa Pharmaceuticals International, plc · NCT07288216An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis
Phase 2 · 18 location(s) · Zomagen Biosciences Ltd. · NCT06836232Phase 2/3 Study of KPL-387 in Recurrent Pericarditis
Phase 2/Phase 3 · 58 location(s) · Kiniksa Pharmaceuticals International, plc · NCT07010159
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.